Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Visfatin and Omentin-1 - Markers of Nutritional Status of Newborns Born to Diabetic Mothers.

NCT04937348 is registered in ClinicalTrials.gov with Wroclaw Medical University as lead sponsor.

NCT NCT04937348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04937348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Visfatin and Omentin-1 - Markers of Nutritional Status of Newborns Born to Diabetic Mothers.
Lead sponsor
Wroclaw Medical University
Phase
Observational
Overall status
Completed
Start date
December 13, 2019
Completion date
March 17, 2021
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, gestational diabetes, neonate, nutritional status